Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO

NCT03602742 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Arrhythmias, Cardiac

Interventions

DEVICE: EZYPRO®

Sponsor

Sigknow Biomedical Co., Ltd.